← Browse by Condition
Medical Condition
kidney transplant complications
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 3, Phase 4
ClinicalMetric tracks all active clinical trials for kidney transplant complications sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — kidney transplant complications Clinical Trials
How many clinical trials are currently recruiting for kidney transplant complications?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for kidney transplant complications, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for kidney transplant complications?
kidney transplant complications research spans Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a kidney transplant complications clinical trial?
Eligibility criteria for kidney transplant complications trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 3 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06379009
Recruiting
Effect of Home-based Training Program for Kidney Transplant Recipients (HOMETRAIN-KTR)
Enrollment
200 pts
Location
Norway
Sponsor
Oslo University Hospital
NCT06440330
Recruiting
Define Predictors for Posttransplant Diabetes Mellitus Study
Enrollment
330 pts
Location
Belgium
Sponsor
University Hospital, Antwerp
NCT06059664 Phase 2
Recruiting
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
Enrollment
100 pts
Location
United States
Sponsor
University of North Carolina, ...
NCT06798909 Phase 3
Recruiting
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
Enrollment
360 pts
Location
United States
Sponsor
University of California, San ...
NCT06958796 Phase 4
Recruiting
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Enrollment
80 pts
Location
United States
Sponsor
Camille N. Kotton, MD
NCT06314230
Recruiting
Australian Genomics Of Chronic Allograft Dysfunction Study
Enrollment
500 pts
Location
Australia
Sponsor
Western Sydney Local Health Di...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology